Syncom Formulations (India) Limited (NSE:SYNCOMF)
India · Delayed Price · Currency is INR 17.49
+0.38 (2.22%)
Aug 19, 2025, 3:29 PM IST
NSE:SYNCOMF Market Cap
NSE:SYNCOMF has a market cap or net worth of 16.39 billion as of August 19, 2025. Its market cap has increased by 10.80% in one year.
Market Cap
16.39B
Enterprise Value
15.54B
Revenue
4.95B
Ranking
n/a
PE Ratio
28.48
Stock Price
17.49
Market Cap Chart
Since December 31, 2001, NSE:SYNCOMF's market cap has increased from 267.05M to 16.39B, an increase of 6,038.81%. That is a compound annual growth rate of 19.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 16.12B | -14.25% |
| Dec 31, 2024 | 18.80B | 32.98% |
| Dec 29, 2023 | 14.14B | 69.37% |
| Dec 30, 2022 | 8.35B | -23.58% |
| Dec 31, 2021 | 10.92B | 305.54% |
| Dec 31, 2020 | 2.69B | 360.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,917.39B |
| Divi's Laboratories | 1,636.48B |
| Cipla | 1,263.32B |
| Apollo Hospitals Enterprise | 1,124.76B |
| Mankind Pharma | 1,020.51B |
| Zydus Lifesciences | 992.65B |
| Fortis Healthcare | 708.34B |
| Alkem Laboratories | 639.37B |